Literature DB >> 827013

An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations.

I Salmi, O Pettay, I Simula, A K Kallio, O Waltimo.   

Abstract

An epidemic due to sulphonamide-resistant group A meningococci started in Finland in January 1973. By the end of 1974 the number of cases exceeded 1300. This report describes epidemiological and clinical observations in 370 patients treated in Helsinki 1973-1974. The incidence was about 65 per 100 000 per year in children under 7 years of age and about 10 per 100 000 in adults. More than one case occurred in 3.8% of the families and in 36% of the lodging-houses of the lowest social group. The fatality rate of patients treated in hospital was 4.1%. Persistent neurological damage was noticed in 4.6%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 827013     DOI: 10.3109/inf.1976.8.issue-4.06

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Clinical aspects of meningococcal infections.

Authors:  V K Paul; I C Verma; A K Deorari
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

2.  Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland.

Authors:  O V Renkonen; A Sivonen; R Visakorpi
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

3.  Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician.

Authors:  P Valmari; H Peltola; O Ruuskanen; H Korvenranta
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

4.  Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.

Authors:  K R Fiebelkorn; S A Crawford; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 5.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

6.  Prevention of secondary cases of meningococcal disease in household contacts by vaccination.

Authors:  B M Greenwood; M Hassan-King; H C Whittle
Journal:  Br Med J       Date:  1978-05-20

7.  Meningococcal disease in Scandinavia.

Authors:  H Peltola; K Jónsdóttir; A Lystad; C J Sievers; I Kallings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.